• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物基因组学:精准医学中不断发展的临床工具。

Pharmacogenomics: An evolving clinical tool for precision medicine.

机构信息

Department of Pharmacy, Cleveland Clinic; Genomic Medicine Institute, Lerner Research Institute, and Center for Personalized Genetic Healthcare, Cleveland Clinic Community Care

Clinical Assistant Professor, Department of Clinical Pharmacy, College of Pharmacy, University of Michigan; Department of Pharmacy, Michigan Medicine, Ann Arbor, MI.

出版信息

Cleve Clin J Med. 2020 Feb;87(2):91-99. doi: 10.3949/ccjm.87a.19073.

DOI:10.3949/ccjm.87a.19073
PMID:32015062
Abstract

Pharmacogenomics, ie, the study of how an individual's genomic profile influences his or her response to drugs, has emerged as a clinical tool to optimize drug therapy. Certain variants in some genes increase the risk of severe, life-threatening adverse effects from certain drugs. Integrating pharmacogenomics into clinical practice to assist in drug selection and dosing has the potential to improve the outcomes of treatment, reduce the risk of drug-induced morbidity and death, and be cost-effective.

摘要

药物基因组学,即研究个体基因组特征如何影响其对药物的反应,已成为优化药物治疗的临床工具。某些基因中的某些变体增加了某些药物引起严重、危及生命的不良反应的风险。将药物基因组学纳入临床实践,以协助药物选择和剂量调整,有可能改善治疗效果,降低药物引起的发病率和死亡率的风险,并具有成本效益。

相似文献

1
Pharmacogenomics: An evolving clinical tool for precision medicine.药物基因组学:精准医学中不断发展的临床工具。
Cleve Clin J Med. 2020 Feb;87(2):91-99. doi: 10.3949/ccjm.87a.19073.
2
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.临床药物基因组学实施联盟指南(CPIC):CYP2D6 和 CYP2C19 基因型与三环类抗抑郁药剂量:2016 年更新。
Clin Pharmacol Ther. 2017 Jul;102(1):37-44. doi: 10.1002/cpt.597. Epub 2017 Feb 13.
3
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.临床药物基因组学实施联盟(CPIC)关于CYP2D6和CYP2C19基因分型与选择性5-羟色胺再摄取抑制剂给药的指南。
Clin Pharmacol Ther. 2015 Aug;98(2):127-34. doi: 10.1002/cpt.147. Epub 2015 Jun 29.
4
Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.临床实践中药物基因组学检测的订购与解读面临的挑战。
Am J Med. 2017 Dec;130(12):1342-1344. doi: 10.1016/j.amjmed.2017.07.012. Epub 2017 Jul 27.
5
Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.精神科中预先性药物基因组学的临床应用:“PREPARE”研究。
Psychiatriki. 2020 Oct-Dec;31(4):341-351. doi: 10.22365/jpsych.2020.314.341.
6
An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.对 5408 名澳大利亚患者 CYP2D6、CYP2C19、CYP2C9 和 VKORC1 基因进行基因分型后的等位基因、基因型和表型频率、可操作的药物基因组学 (PGx) 变异体和表型转化分析。
J Neural Transm (Vienna). 2019 Jan;126(1):5-18. doi: 10.1007/s00702-018-1922-0. Epub 2018 Sep 6.
7
Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs.药物遗传学影响细胞色素P450代谢药物的剂量、疗效和毒性。
Am J Med. 2002 Dec 15;113(9):746-50. doi: 10.1016/s0002-9343(02)01363-3.
8
CYP2C19 and CYP2D6 genotypes in Pacific peoples.太平洋人群中的CYP2C19和CYP2D6基因分型
Br J Clin Pharmacol. 2016 Nov;82(5):1303-1307. doi: 10.1111/bcp.13045. Epub 2016 Aug 26.
9
Precision dosing for patients on tricyclic antidepressants.三环类抗抑郁药患者的精准剂量。
Pharmacogenet Genomics. 2024 Jun 1;34(4):117-125. doi: 10.1097/FPC.0000000000000527. Epub 2024 Mar 11.
10
Clinical Outcomes and Sustainability of Using Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后使用基于基因型的抗血小板治疗的临床结果和可持续性。
Circ Genom Precis Med. 2018 Apr;11(4):e002069. doi: 10.1161/CIRCGEN.117.002069.

引用本文的文献

1
DTreePred: an online viewer based on machine learning for pathogenicity prediction of genomic variants.DTreePred:一种基于机器学习的在线基因组变异致病性预测查看器。
BMC Bioinformatics. 2025 Apr 9;26(1):101. doi: 10.1186/s12859-025-06113-4.
2
Pharmacogenomic curriculum in Australian medical schools: a content analysis study.澳大利亚医学院校的药物基因组学课程:一项内容分析研究。
Pharmacogenomics. 2024;25(16-18):647-655. doi: 10.1080/14622416.2025.2452834. Epub 2025 Jan 17.
3
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy.
患者来源的肿瘤类器官:个性化癌症治疗的临床前平台。
Transl Oncol. 2025 Jan;51:102226. doi: 10.1016/j.tranon.2024.102226. Epub 2024 Dec 1.
4
PGxDB: an interactive web-platform for pharmacogenomics research.PGxDB:一个用于药物基因组学研究的交互式网络平台。
Nucleic Acids Res. 2025 Jan 6;53(D1):D1486-D1497. doi: 10.1093/nar/gkae1127.
5
Biomarkers in the Diagnosis and Prediction of Medication Response in Depression and the Role of Nutraceuticals.生物标志物在抑郁症药物反应的诊断和预测中的作用及营养保健品的作用。
Int J Mol Sci. 2024 Jul 22;25(14):7992. doi: 10.3390/ijms25147992.
6
Evaluation of Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi.广西壮族和汉族精神分裂症患者基因变异及其与丙戊酸血药浓度的相关性评估
Pharmgenomics Pers Med. 2024 May 14;17:225-236. doi: 10.2147/PGPM.S457805. eCollection 2024.
7
Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study.抗精神病药物中具有 CYP2D6 药物遗传学(PGx)关联的比例在精神病早期干预(EIP)队列中的处方情况:一项横断面研究。
J Psychopharmacol. 2024 Apr;38(4):382-394. doi: 10.1177/02698811241238283. Epub 2024 Mar 17.
8
Healthcare professionals' and consumers' knowledge, attitudes, perspectives, and education needs in oncology pharmacogenomics: A systematic review.肿瘤药理学基因组学中医疗保健专业人员和消费者的知识、态度、观点和教育需求:系统评价。
Clin Transl Sci. 2023 Dec;16(12):2467-2482. doi: 10.1111/cts.13672. Epub 2023 Nov 22.
9
The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics.药剂师在药物基因组学临床应用中的潜在作用。
Pharmacy (Basel). 2023 Nov 19;11(6):180. doi: 10.3390/pharmacy11060180.
10
Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases.迈向南部非洲基于证据的药物基因组学实施:跨疾病的合并症和多药治疗情况
J Pers Med. 2023 Jul 26;13(8):1185. doi: 10.3390/jpm13081185.